Originally created 12/07/00


Andres Galarraga has turned down the most recent offer from the Atlanta Braves and is drawing interest from several other teams.

Jim Bronner, Galarraga's agent, spoke with the Braves on Wednesday about the first baseman, whose $24.75 million, three-year contract expired at the end of the season. Bronner declined to say what the value of the offer was.

Braves general manager John Schuerholz declined comment on the subject. Galarraga, 39, missed the 1999 season because of cancer, but came back to hit .302 with 28 homers and 100 RBI during the 2000 campaign.

Elsewhere around the majors:

The Los Angeles Dodgers signed right-hander Andy Ashby to a $22.5 million, three-year contract. Ashby, 33, was 12-13 with a 4.92 ERA in 31 starts for the Braves and Phillies last season.

The New York Mets signed right-hander Rick Reed to a three-year deal worth about $21.75 million. Reed, a 36-year-old right-hander, was 11-5 with a 4.11 ERA in 30 starts last season.

Former Braves infielder Ozzie Guillen, Tampa Bay's lone free agent, re-signed with the Devil Rays, agreeing to a minor league contract with an invitation to spring training. Guillen, 36, hit .243 in 63 games last season.

The Arizona Diamondbacks re-signed right-hander Armando Reynoso to a two-year, $6.5 million contract. He was 11-12 with a 5.27 ERA last season.


The Dallas Cowboys released running back Chris Warren, who ran 59 times for 254 yards and two touchdowns this season. He also caught 31 passes for 302 yards. ... Detroit Lions quarterback Charlie Batch put his bruised ribs through a full practice without any problems, and the team will determine today if he will start Sunday's game against the Green Bay Packers. ... San Diego Chargers coach Mike Riley admitted he has spoken to USC officials about its vacant coaching job, but said he hasn't been offered the position.


Swedish tennis star Thomas Enqvist had surgery on his left foot and right shoulder and is expected to be sidelined at least until March.


Trending this week:


© 2018. All Rights Reserved.    | Contact Us